June 1 (Reuters) - Arch Biopartners Inc ACH.V :
* European Commission designated AB569 as orphan medicinal
product in European Union for treatment of patients with cystic
fibrosis
Source text for Eikon: ID:nMKWL46zLa
Further company coverage: ACH.V